Cite
Model-informed intermittent tenofovir disoproxil fumarate and emtricitabine dosing for HIV pre-exposure prophylaxis in subjects with renal impairment: a case report.
MLA
Zino, Leena, et al. “Model-Informed Intermittent Tenofovir Disoproxil Fumarate and Emtricitabine Dosing for HIV Pre-Exposure Prophylaxis in Subjects with Renal Impairment: A Case Report.” AIDS (02699370), vol. 37, no. 2, Feb. 2023, pp. 363–65. EBSCOhost, https://doi.org/10.1097/QAD.0000000000003438.
APA
Zino, L., Jacobs, T. G., Nieuwenstein, T., Grintjes, K., Colbers, A., & Burger, D. M. (2023). Model-informed intermittent tenofovir disoproxil fumarate and emtricitabine dosing for HIV pre-exposure prophylaxis in subjects with renal impairment: a case report. AIDS (02699370), 37(2), 363–365. https://doi.org/10.1097/QAD.0000000000003438
Chicago
Zino, Leena, Tom G. Jacobs, Thomas Nieuwenstein, Karin Grintjes, Angela Colbers, and David M. Burger. 2023. “Model-Informed Intermittent Tenofovir Disoproxil Fumarate and Emtricitabine Dosing for HIV Pre-Exposure Prophylaxis in Subjects with Renal Impairment: A Case Report.” AIDS (02699370) 37 (2): 363–65. doi:10.1097/QAD.0000000000003438.